Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms
This partnership focuses on supporting Incyte's investigational therapies, including the monoclonal antibody INCA033989, which targets mutant calreticulin (mutCALR) in conditions such as myelofibrosis (MF) and essential thrombocythemia (ET).
According to the agreement, Qiagen will create a multimodal panel leveraging next-generation sequencing (NGS) to detect clinically relevant gene alterations in haematological malignancies.
The validation of the panel will be done by the Illumina NextSeq 550Dx platform as part of Qiagen's collaboration with the latter to provide NGS diagnostic platforms for global laboratory testing.
Regulatory submissions and market access activities will be supported by Qiagen across the European Union, the US, and the Asia-Pacific regions.
According to Qiagen, MPNs account for approximately 40% of haematological malignancies and are marked by the overproduction of various mature blood cells.
Incyte research and development head and president Pablo Cagnoni said: 'Following our presentation of positive, late-breaking data from our first-in-class mutCALR-targeted antibody at EHA, we are excited to announce this partnership with Qiagen, which will facilitate CALR testing for patients with MPNs on a global basis.
'The development of companion diagnostics for mutCALR, coupled with the potential for new medicines to selectively target disease-initiating cells, is a critical step toward changing the course of disease in patients with ET and MF.'
Incyte's INCA033989 for mutCALR ET or MF aims to eliminate malignant cells while sparing healthy ones.
CALR is said to play a crucial role in managing calcium levels within cells and ensuring the production of proteins.
Last month, Qiagen entered a commercial collaboration and joint marketing agreement with ID Solutions to expand the availability of digital polymerase chain reaction (dPCR) assays for applications in oncology research.
"Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
an hour ago
- USA Today
Liberals play partisan games with economic news
Will Democrats put politics aside and applaud as the American economy shows a strength and resilience that so many of them doubted? Probably not. Thanks to President Donald Trump's bold policies, it appears that the United States will avoid a recession this year − one that so many liberals were predicting only months ago. Will Democrats put politics aside and applaud as the American economy shows a strength and resilience that so many of them doubted? Probably not. The Bureau of Economic Analysis on July 30 released more good news about our nation's vibrant economy. Gross domestic product grew a healthy annual rate of 3% in the second quarter after recording a less than 1% decline in the first three months of this year. Fears of a recession should now dissipate like morning haze after the sunrise. Nearly all markers of a strong economy are in top form. Unemployment is low, hovering at 4.1%. The past three months have seen steady job growth. Average hourly earnings for U.S. workers grew 3.7% over the 12 months ending in June. Consumer spending is expected to rise, and there's been a modest uptick in consumer confidence. The Consumer Price Index, which measures inflation, increased 2.7% over the 12 months ending in June, far below the 40-year high recorded in President Joe Biden's term. Even the average price of eggs has dropped dramatically, to $3.31 per dozen, down from a spike to $8 in February and back to roughly the same price level as a year ago. Stock indexes continue to grow at a strong pace, recovering from the sell-off this spring driven by concerns over Trump's tariffs. The Nasdaq and S&P 500 have set multiple record highs in July, a boon to millions of Americans with retirement accounts and other investors. On the tariff front, Trump's new trade deal with the European Union should be a catalyst for further economic growth, particularly in the energy and construction sectors. If this is what a recession looks like, let's keep it coming. Critics said Trump was destroying the economy Despite such healthy economic markers, I doubt I'll see many kudos offered to the Trump administration for powering past a recession, which the left predicted in doomsday terms. Nobel Prize-winning economist Paul Krugman wrote in May that Trump and "MAGAnomics" were "destroying the economy and waging war on the middle class and the poor." The headline thundered that Trump was "making America backward again." Opinion: Trump's EU trade deal ushers in a golden age for blue-collar workers Interestingly, Krugman claimed that the U.S. economy was in good overall shape when Biden left office in January. He charged Trump with wrecking the economy in a mere three months. Now, that the data clearly shows otherwise, will Krugman admit his errors? I doubt it. Krugman, to be fair, wasn't the only so-called expert spouting off about our supposedly crumbling economy. CNN published an analysis in April with a headline that claimed "Trump took the US economy to the brink of a crisis in just 100 days." That same month, the Center for American Progress bemoaned that "President Donald Trump's decision to unilaterally launch a global trade war could be one of the worst economic statecraft blunders in American history." Opinion newsletter: Sign up for our newsletter on conservative values, family and religion from columnist Nicole Russell. Get it delivered to your inbox. I read these articles in the mainstream news media and wonder if we share the same universe. Do progressives not see the same healthy economic markers that millions of other Americans and I see? The answer, of course, is that they do see − but they are too blinded by partisanship to admit it. Good economic news should be nonpartisan I don't have a problem with liberals criticizing Trump. Sometimes he deserves it. But when it comes to obvious wins like a blossoming economy, the constant derision is tiresome and pedestrian. A robust economy under any president is good news for Americans, regardless of their party affiliation. Right? I didn't care for Biden's leftist policies. But I didn't cheer when the economy struggled. It was bad news not just for Biden but, far more important, also for our nation and its citizens. More than a year after Biden entered the White House, annual inflation spiked to 9% in June 2022, the highest rate in four decades. Americans were hit with sudden increases in food, housing and transportation costs. Opinion: Nvidia CEO says Trump gives America an advantage. Hear that, progressives? Compounding the pain, the Federal Reserve acted to cool inflation by raising interest rates, which pushed up consumers' payments for auto, housing and credit card loans. Democrats tried to blame decisions made in Trump's first term, including federal spending used to fight consequences of the COVID-19 pandemic. But Biden spent more even as the pandemic began to wane. In 2024, more than half of American voters said the economy was the issue that mattered to them the most. It's why Trump won more than 77 million votes and returned to the White House. Now, he is delivering on his promises to rebuild our nation's economy. But not everyone is happy about it. It's too bad liberals can't separate economic success from Trump's party affiliation. I can't help but wonder if they wanted a recession so they could blame Trump even more. Nicole Russell is a columnist at USA TODAY and a mother of four who lives in Texas. Contact her at nrussell@ and follow her on X, formerly Twitter: @russell_nm. Sign up for her weekly newsletter, The Right Track, here. You can read diverse opinions from our USA TODAY columnists and other writers on the Opinion front page, on X, formerly Twitter, @usatodayopinion and in our Opinion newsletter.
CNBC
an hour ago
- CNBC
Trump advisor Peter Navarro slams India's ‘opportunistic' purchases of Russian crude
U.S. President Donald Trump's trade advisor Peter Navarro on Monday called on India to stop buying Russian crude oil, accusing the Asian giant of undermining international efforts to isolate Vladimir Putin's war economy. Writing in in the Financial Times, Navarro described India's dependence on Russian oil as "opportunistic," adding that if India "wants to be treated as a strategic partner of the US, it needs to start acting like one." "In effect, India acts as a global clearinghouse for Russian oil, converting embargoed crude into high-value exports while giving Moscow the dollars it needs," Navarro said in the op-ed. His comments come shortly after trade negotiations between the U.S. and India, which had been scheduled to take place in New Delhi later this month, were reportedly called off. India's Ministry of Commerce and Industry, and the Office of the U.S Trade Representative did not immediately respond to CNBC's request for comments. Earlier this month, the Trump administration said it planned to impose an additional 25% tariff on India over Russian oil purchases, bringing the total levies against the country to 50%. The cumulative rate of duties on India is among the highest on any of Washington's trade partners. India described the move as "extremely unfortunate" at the time, saying the tariffs were "unfair, unjustified and unreasonable." The White House has since warned that secondary levies on India could increase further, depending on the outcome of Trump's peace talks with Putin. For its part, India has said it has been unfairly targeted for its continuing trade with Russia since Moscow's full-scale invasion of Ukraine in early 2022, amid criticism from both the U.S. and European Union. In a statement published Aug. 4, India's Ministry of External Affairs said the country began importing from Russian because traditional supplies were diverted from Europe after the outbreak of the conflict. "India's imports are meant to ensure predictable and affordable energy costs to the Indian consumer. They are a necessity compelled by global market situation," India's Ministry of External Affairs said. "However, it is revealing that the very nations criticizing India are themselves indulging in trade with Russia. Unlike our case, such trade is not even a vital national compulsion," it added. Trump's criticism of India's oil trade with Russia represents a clear shift from the Biden administration, which, along with other G7 nations, Australia and the European Union, established a $60 a barrel price cap in late 2022. The EU has since signaled it has reached an agreement to lower the price threshold. This mechanism sought to limit Russia's revenue from oil sales, while maintaining some stability in global energy markets. Shilan Shah, deputy chief emerging markets economist at Capital Economics, said India could, in principle, find suppliers other than Russia to meet its energy needs "relatively easily," with limited economic impact. "But we doubt that India would make a wholehearted effort to wean itself off Russian oil. Domestically, it would not play well to be seen caving to Trump's demands," Shah said in a note published Aug. 4. "In addition, Indian policymakers would be reluctant to upend generally cordial (and long-standing) relations with Russia," he added.
Bloomberg
2 hours ago
- Bloomberg
China Extends Probe Into EU Dairy Imports for Another Six Months
China will extend its probe into dairy imports from the European Union for another six months, delaying a decision as tensions linger between the two trade partners. The investigation, launched in August last year, has now been extended till Feb. 21 next year, due to the 'complexity of the case,' the commerce ministry said in a statement released on its website.
